tiprankstipranks
TOT BIOPHARM International Co. Ltd. (HK:1875)
:1875
Hong Kong Market
1875
TOT BIOPHARM International Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:1875 full AI Analyst Report?

TOT BIOPHARM International Co. Ltd. (1875) Income Statement

0 Followers

TOT BIOPHARM International Co. Ltd. Income Statement

Last quarter (Q4 2025), TOT BIOPHARM International Co. Ltd.'s total revenue was ¥258.50M, a decrease of -42.88% from the same quarter last year. In Q4, TOT BIOPHARM International Co. Ltd.'s net income was ¥-104.43M. See TOT BIOPHARM International Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 747.64M¥ 1.10B¥ 780.63M¥ 442.18M¥ 76.33M
Gross Profit
¥ 388.98M¥ 782.43M¥ 573.99M¥ 370.62M¥ 27.47M
Operating Expenses
¥ 479.67M¥ 741.18M¥ 607.05M¥ 409.45M¥ 287.17M
Depreciation and Amortization
¥ 74.05M¥ 38.80M¥ 43.03M¥ 38.04M¥ 34.24M
EBITDA
¥ -6.44M¥ 84.96M¥ 10.45M¥ -5.41M¥ -224.51M
Operating Income
¥ -90.69M¥ 41.25M¥ -33.06M¥ -39.08M¥ -259.70M
Other Income/Expenses
¥ -9.68M¥ -6.50M¥ -4.70M¥ -10.97M¥ -1.52M
Pretax Income
¥ -100.37M¥ 34.76M¥ -37.76M¥ -50.05M¥ -261.22M
Net Income
¥ -100.37M¥ 34.76M¥ -37.76M¥ -49.92M¥ -261.22M
Per Share Metrics
Basic EPS
¥ -0.14¥ 0.05¥ -0.05¥ -0.08¥ -0.46
Diluted EPS
¥ -0.14¥ 0.05¥ -0.05¥ -0.08¥ -0.46
Weighted Average Shares Outstanding
 725.20M 725.21M 725.20M 639.31M 573.36M
Weighted Average Shares Outstanding (Diluted)
 725.20M 725.20M 725.20M 639.31M 573.36M
Currency in CNY

TOT BIOPHARM International Co. Ltd. Earnings and Revenue History